Humboldt Fund is an investment firm that seeks to invests in bio revolution companies.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Humboldt Fund is an investment firm that seeks to invests in bio revolution companies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2020 | Metagenomi | Series A | 0 |
10/2020 | MycoWorks | Series B | 0 |
1/2022 | Cellino Biotech | Series A | 0 |
2/2021 | Cellino Biotech | Seed Round | 16M |
8/2019 | Metagenomi | Series A | 0 |
2/2022 | HAYA Therapeutics | Seed Round | 0 |
4/2022 | Ansa Biotechnologies | Series A | 68M |
9/2020 | Finch Therapeutics | Series D | 0 |
4/2021 | Mission Barns | Series A | 0 |
8/2021 | Compound Foods | Seed Round | - |
9/2021 | Compound Foods | Seed Round | 0 |
7/2020 | Geltor | Series B | 0 |
1/2023 | Spiral Therapeutics | Venture Round | 8.3M |
6/2022 | Endpoint Health | Series A | 0 |
1/2022 | Metagenomi | Series B | 0 |
12/2022 | Deciduous Therapeutics | Seed Round | 10M |
3/2021 | Meatable | Series A | 47M |
8/2021 | Debut Biotech | Series A | 0 |
8/2020 | CellX | Pre Seed Round | 500k |
12/2020 | Concerto Biosciences | Seed Round | 1.5M |
3/2022 | Affini-T Therapeutics | Venture Round | 0 |
3/2022 | Finless Foods | Series B | 0 |
6/2020 | Ansa Biotechnologies | Seed Round | 7.9M |
10/2021 | Ansa Biotechnologies | Equity | 5M |
6/2022 | Endpoint Health | Series A | 0 |
4/2022 | Ansa Biotechnologies | Series A | 0 |
3/2022 | Affini-T Therapeutics | Venture Round | 0 |
3/2022 | Finless Foods | Series B | 0 |
2/2022 | HAYA Therapeutics | Seed Round | 0 |
1/2022 | Metagenomi | Series B | 0 |
1/2022 | Cellino | Series A | 0 |
10/2021 | Ansa Biotechnologies | Funding Round | 0 |
9/2021 | Compound Foods | Seed Round | 0 |
8/2021 | Compound Foods | Seed Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|